DOXORUBICINE TEVA 50 mg/25 mL, solution injectable

Business Listing - September 04, 2021

DOXORUBICINE TEVA 50 mg/25 mL, solution injectable

DOXORUBICINE TEVA 50 mg/25 mL, solution injectable solution injectable intraveineuse Autorisation active Procédure nationale Commercialisée 2/26/1996 TEVA SANTE

Tags & Categories

intraveineuse active solution injectable autorisation procédure commercialisée nationale sante doxorubicine

Featured

This is a premium business listing. Stand out from the competition!

Own a Business?

List your company and reach more customers today.

Add Your Business